University of Louisville

Impact of Developmental Cigarette Smoke Exposure on Offspring Mortality and Motor Development

Grade Level at Time of Presentation

Junior

Major

Neuroscience

Minor

Biology

Institution 23-24

University of Louisville

KY House District #

37

KY Senate District #

38

Department

Biology

Abstract

Kentucky has the second highest rate of maternal cigarette smoking in the country at 15.7%, though the true number is likely higher due to inaccurate self-reports. Constituents of cigarette smoke like nicotine, carbon monoxide, and tar not only can adversely affect the adult smoker but also pose a significant threat to embryonic and fetal development. Children born to mothers who smoked during pregnancy are more likely to be born prematurely and/or underweight, or with physical abnormalities.

We developed a revised cigarette smoke exposure (CSE) model lasting 3hrs/day, contrasting with our previous 6hr exposure model, with the goal of assessing whether this new model yields similar outcomes to the 6hr model. Female C57Bl/6 mice were exposed to cigarette smoke (CSE, n=30) or filtered room air (Sham, n = 20) for 3hrs/day starting at 4 days prior to mating and continuing until the day before delivery. Measures analyzed include birth weight and weight gain, eye opening, surface righting, postnatal survival, % fat accumulation, and parameters of liver damage found in plasma after euthanization.

We hypothesized that even a moderate daily exposure duration would result in decreased maternal fertility, offspring viability, and delay reflex development. We report a higher postnatal mortality rate in CSE offspring, usually due to failure to thrive. A sex-dependent effect of prenatal CSE on motor development was observed through surface righting on postnatal days 3–8 (p=0.03). We conclude that our cigarette smoking model is sufficient to produce increased offspring mortality and a delay in postnatal motor development, even in the absence of postnatal exposure. We are currently testing prenatal CSE effects on adult metabolic response to a high-fat, high-fructose diet.

Funding: NIH R15ES028440-02A1

This document is currently not available here.

Share

COinS
 

Impact of Developmental Cigarette Smoke Exposure on Offspring Mortality and Motor Development

Kentucky has the second highest rate of maternal cigarette smoking in the country at 15.7%, though the true number is likely higher due to inaccurate self-reports. Constituents of cigarette smoke like nicotine, carbon monoxide, and tar not only can adversely affect the adult smoker but also pose a significant threat to embryonic and fetal development. Children born to mothers who smoked during pregnancy are more likely to be born prematurely and/or underweight, or with physical abnormalities.

We developed a revised cigarette smoke exposure (CSE) model lasting 3hrs/day, contrasting with our previous 6hr exposure model, with the goal of assessing whether this new model yields similar outcomes to the 6hr model. Female C57Bl/6 mice were exposed to cigarette smoke (CSE, n=30) or filtered room air (Sham, n = 20) for 3hrs/day starting at 4 days prior to mating and continuing until the day before delivery. Measures analyzed include birth weight and weight gain, eye opening, surface righting, postnatal survival, % fat accumulation, and parameters of liver damage found in plasma after euthanization.

We hypothesized that even a moderate daily exposure duration would result in decreased maternal fertility, offspring viability, and delay reflex development. We report a higher postnatal mortality rate in CSE offspring, usually due to failure to thrive. A sex-dependent effect of prenatal CSE on motor development was observed through surface righting on postnatal days 3–8 (p=0.03). We conclude that our cigarette smoking model is sufficient to produce increased offspring mortality and a delay in postnatal motor development, even in the absence of postnatal exposure. We are currently testing prenatal CSE effects on adult metabolic response to a high-fat, high-fructose diet.

Funding: NIH R15ES028440-02A1